Literature DB >> 9059881

Specificity, tolerance and developmental regulation of natural killer cells defined by expression of class I-specific Ly49 receptors.

D H Raulet1, W Held, I Correa, J R Dorfman, M F Wu, L Corral.   

Abstract

Natural killer cells in the mouse express class I MHC-specific inhibitory receptors of the Ly49 protein family. The receptors mediate inhibition of the lysis of tumor cells and normal cells, and mediate the specificity of bone-marrow graft rejection by NK cells in vivo. The function of these receptors may be to confer upon NK cells the capacity to distinguish normal self cells from cells that have down-regulated expression of some or all self-class I molecules. Ly49 receptors discriminate between different class I molecules, and are distributed in expression to overlapping subsets of NK cells. The receptors appear to interact with class I-MHC residues and associated N-glycans, with little or no discrimination of the class I-bound peptide. The Ly49 receptor repertoire may be initially generated by a stochastic process that distributes receptors randomly to different cells and treats the two alleles of a given Ly49 gene independently. However, class I-MHC-dependent "education" processes shape the functional repertoire. The education processes silence potentially auto-aggressive NK cells, probably by ensuring that each NK cell expresses at least one self-specific Ly49 receptor. In addition, NK cell clones that express multiple self-specific Ly49 receptors are disfavored by the education processes, perhaps to confer greater discrimination on to individual NK cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9059881     DOI: 10.1111/j.1600-065x.1997.tb00938.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  47 in total

1.  Natural killer cell acceptance of H-2 mismatch bone marrow grafts in transgenic mice expressing HLA-Cw3 specific killer cell inhibitory receptor.

Authors:  A Cambiaggi; C Verthuy; P Naquet; F Romagné; P Ferrier; R Biassoni; A Moretta; L Moretta; E Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.

Authors:  Markus Sköld; Martin Stenström; Stephane Sidobre; Petter Höglund; Mitchell Kronenberg; Susanna Cardell
Journal:  Immunology       Date:  2003-11       Impact factor: 7.397

3.  Complex expression of natural killer receptor genes in single natural killer cells.

Authors:  Zaheed Husain; Chester A Alper; Edmond J Yunis; Devendra P Dubey
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

Review 4.  Innate immune control of HIV.

Authors:  Mary Carrington; Galit Alter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-07       Impact factor: 6.915

Review 5.  Current perspectives of natural killer cell education by MHC class I molecules.

Authors:  Petter Höglund; Petter Brodin
Journal:  Nat Rev Immunol       Date:  2010-09-06       Impact factor: 53.106

6.  Activation or tolerance of natural killer cells is modulated by ligand quality in a nonmonotonic manner.

Authors:  Jayajit Das
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

7.  A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules.

Authors:  Nadine C Fernandez; Emmanuel Treiner; Russell E Vance; Amanda M Jamieson; Suzanne Lemieux; David H Raulet
Journal:  Blood       Date:  2005-02-22       Impact factor: 22.113

8.  Activation of Natural Killer Cells by Probiotics.

Authors:  Nabil Aziz; Benjamin Bonavida
Journal:  For Immunopathol Dis Therap       Date:  2016

Review 9.  The balancing act: inhibitory Ly49 regulate NKG2D-mediated NK cell functions.

Authors:  Subramaniam Malarkannan
Journal:  Semin Immunol       Date:  2006-06       Impact factor: 11.130

10.  Complexity in the cattle CD94/NKG2 gene families.

Authors:  James Birch; Shirley A Ellis
Journal:  Immunogenetics       Date:  2007-02-07       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.